Tower Research Capital LLC (Trc) Sqz Biotechnologies CO Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.27 - $0.68 $66 - $167	-246 Reduced 3.72%	6,368 $1,000
Q1 2023 May 09, 2023	SELL	$0.53 - $0.87 $1,939 - $3,184	-3,660 Reduced 35.62%	6,614 $4,000
Q4 2022 Feb 10, 2023	SELL	$0.67 - $2.85 $192 - $817	-287 Reduced 2.72%	10,274 $7,000
Q3 2022 Nov 10, 2022	BUY	$2.16 - $3.48 $22,811 - $36,752	10,561 New	10,561 $24,000
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $6,243 - $11,270	-2,254 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.01 - $10.42 $3,673 - $9,544	916 Added 68.46%	2,254 $11,000
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $7,027 - $11,686	787 Added 142.83%	1,338 $12,000
Q3 2021 Nov 15, 2021	SELL	$11.46 - $15.77 $175,062 - $240,902	-15,276 Reduced 96.52%	551 $8,000
Q2 2021 Aug 16, 2021	BUY	$11.32 - $14.45 $156,385 - $199,626	13,815 Added 686.63%	15,827 $228,000
Q1 2021 May 17, 2021	BUY	$12.07 - $29.9 $19,070 - $47,242	1,580 Added 365.74%	2,012 $28,000
Q4 2020 Feb 16, 2021	BUY	$13.25 - $34.58 $5,724 - $14,938	432 New	432 $13,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.